EBOLA VIRUS DISEASE

CSL looks to purify Ebola victim antibodies

roymorgansocial Leave a comment

Original article by Pia Akerman
The Australian – Page: 21 : 16-Oct-14

John Shine, chair of Australian-listed biotechnology group CSL, addressed its AGM on 15 October 2014. He said the company was in talks with the World Health Organisation on a potential push to create new drugs for the fight against the Ebola virus. However there are no immediate plans for the development of a vaccine, which is at least a year away according to CEO Paul Perreault. Meanwhile CSL has announced a $A950m stock repurchasing scheme, following six previous such moves that were worth $A3.3bn combined

CORPORATES
CSL LIMITED – ASX CSL, WORLD HEALTH ORGANIZATION

Researchers cut at Ebola laboratory

roymorgansocial Leave a comment

Original article by Nicky Phillips, Phillip Thomson, Bridie Smith
The Sydney Morning Herald – Page: 7 : 15-Aug-14

The Australian Government’s May 2014 Budget contained funding cuts of $A111m over four years for the CSIRO research body. It has now been claimed by the CSIRO Staff Association that as many as eight researchers will be made redundant at its Australian Animal Health Laboratory. The facility in Geelong is the only one in the nation equipped to handle live samples of dangerous viruses such as ebola. The cuts are criticised by Australian Infectious Disease Research Centre director Mark Walker and Nobel Prize winner Peter Doherty. Kurt Zuelke, director of the Biosecurity Flagship at CSIRO, says research on the Hendra virus and avian influenza will remain unaffected

CORPORATES
CSIRO, CSIRO. AUSTRALIAN ANIMAL HEALTH LABORATORY, CSIRO STAFF ASSOCIATION, UNIVERSITY OF QUEENSLAND. AUSTRALIAN INFECTIOUS DISEASES RESEARCH CENTRE, NOBEL FOUNDATION